AGP Picks
View all

SocialRx recognized as a 2026 Fierce 50 honoree

SocialRx has been named a Fierce 50 honoree for 2026

SocialRx has been named a Fierce 50 honoree for 2026

Atlanta-based SocialRx recognized by Fierce Healthcare for driving advancements in medicine, fostering innovation and shaping the future of and healthcare.

We know connection and community have a meaningful impact on our health. SocialRx’s inclusion in the Fierce 50 signals that the industry is ready to treat community connection as real infrastructure.”
— Chris Appleton, CEO of SocialRx
ATLANTA, GA, UNITED STATES, September 1, 2026 /EINPresswire.com/ -- SocialRx has been named a 2026 Fierce 50 honoree by Fierce Pharma, Fierce Biotech and Fierce Healthcare. The Fierce 50 recognizes 50 individuals and organizations driving advancements in medicine, fostering innovation and shaping the future of biopharma and healthcare.

“Now in its fourth year, the Fierce 50 continues to show that progress in this industry doesn’t come from just one place,” said Ayla Ellison, editor-in-chief of Fierce Life Sciences and Healthcare. “It’s showing up in the lab, in executive leadership, in community clinics and in advocacy work that never makes headlines. Whether it’s a biotech pushing a new therapy toward patients or a grassroots organization fighting for someone to get the care they need, these honorees remind us that impact takes a lot of different shapes. We’re honored to celebrate all of them.”

Based in Atlanta, SocialRx is developing the infrastructure to make social prescribing measurable and scalable for healthcare. By pairing care navigation and technology with evidence-based outcomes tracking, SocialRx connects patients to the community experiences that improve mental health and well-being — turning a 40-year-old care model into a system healthcare can actually run on. SocialRx was recognized in the Social Impact category for this work.

“Loneliness and social isolation show up in exam rooms every day, even when they're not what brought someone through the door,” said Chris Appleton, founder and CEO of SocialRx. “We know connection and community have a meaningful impact on health outcomes, but providers didn’t have a structured way to recommend these interventions and track them. SocialRx’s inclusion in the Fierce 50 signals that the industry is ready to treat community connection as real infrastructure, not an afterthought. We're honored by the recognition, and especially grateful to the health systems, health plans, and community partners who have trusted us to build that infrastructure with them.”

Chosen by the editors of Fierce Pharma, Fierce Biotech and Fierce Healthcare, this year's Fierce 50 honorees reflect the breadth of talent and vision shaping the biopharma and healthcare industries today. From startups to established organizations, each has made a distinct contribution, whether by advancing scientific discovery, improving the health of communities, expanding access to care or reimagining how healthcare is delivered at a local level or on a global scale.

About SocialRx
SocialRx is the leading social prescribing platform in the United States that connects patients to community-based experiences that address the mental health and loneliness crises, using care navigation and evidence-based outcomes tracking. Founded in 2022 and based in Atlanta, the company is building the infrastructure that makes social prescribing a measurable, scalable part of clinical care.

About Fierce Pharma
Fierce Pharma is the go-to destination for the news and trends shaping the industry. Our focus daily is on news about approved drugs and every aspect of pharma’s operations as well as the people who move pharma forward. Our coverage also feeds longer-form content, podcasts and events. In staying on top of the news, our journalists have developed a loyal audience. Critically, we explain the news—often complicated technology or business maneuvers—and put it in context that brings it home for our readers and listeners in their work lives.

About Fierce Biotech
Fierce Biotech is the dominant B2B news brand for the industry. Every day, we track the companies, people and ideas reshaping biotech: from the discovery through clinical trials, approvals and commercialization, and the venture funding, partnerships, IPOs and M&A that power it all. That reporting fuels our long-form features, podcasts and events, where deal flow, data and on-the-ground insight come together into the fullest picture of where the industry is headed.

About Fierce Healthcare
At Fierce Healthcare, we deliver the news and analysis that healthcare can't afford to miss. Our newsroom serves the people building, running, and reshaping this industry: hospital executives and physicians, payers, policymakers, researchers and the entrepreneurs betting on what comes next. Wherever healthcare is being disrupted, financed, regulated, or reinvented, we're covering it, with breaking news, exclusive interviews and deep reporting that connects the dots between a boardroom decision and a patient's bedside experience.
###

Jess Newfield
SocialRx
+1 919-593-1518
jess@socialrx.com
Visit us on social media:
LinkedIn
Instagram
Facebook
YouTube

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Global Business Watch

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.